Data Repositories & Centralized Registries
Centralised databases and registries collecting structured data on psychedelic therapy outcomes and safety signals.
All Organisations
Australian New Zealand Clinical Trials Registry
WHO primary clinical trial registry for Australia and New Zealand, used for trial discovery and protocol metadata. Psychedelic relevance: registry infrastructure includes psychedelic trial records via search, but no dedicated psychedelic evidence vertical.
Brazilian Clinical Trials Registry
Brazil's public clinical trial registry platform for experimental and non-experimental studies in humans. Psychedelic-specific indexing is not offered as a dedicated registry surface.
CTIS (Clinical Trials Information System)
EU clinical trial public portal with explicit psilocybin trial records currently visible.
Chinese Clinical Trial Registry (ChiCTR)
WHO primary trial registry for China with broad trial metadata coverage. Psychedelic-specific datasets are not presented as a dedicated public vertical.
Clarivate Cortellis
Commercial intelligence platform with clinical, regulatory, and real-world evidence datasets for biopharma decision support.
ClinicalTrials.gov
US National Library of Medicine registry and results database with broad global trial coverage, including many psychedelic studies.
EudraCT (EU Clinical Trials Register, legacy)
Legacy EU clinical trials register still relevant for historical records and legacy IDs linked from CTIS; includes trial history relevant to psychedelic development tracking.
German Clinical Trials Register
Primary registry for clinical trials in Germany, recognized by WHO as the national primary registry. Psychedelic-specific data is not provided as a dedicated public vertical.
HMA-EMA Catalogues of Real-World Data Sources and Studies
European catalogues that centralize metadata on real-world data sources and RWD studies for regulatory and research discoverability. These catalogues replaced older ENCePP/EU PAS register-era database surfaces.
IQVIA Real World Data
Commercial real-world data products and linked evidence assets used in life sciences research and regulatory support.
ISRCTN Registry
Primary clinical trial registry with global participation and searchable records including psychedelic-related studies; no dedicated psychedelic-specific product surface.
WHO ICTRP
WHO global trial-search aggregator across multiple primary registries. Psychedelic records are present via source registries, but ICTRP does not provide a dedicated psychedelic evidence vertical.